Only 4.3% of reported illegal medical advertising cases in South Korea led to material penalties such as fines or criminal referrals. From 2021 through the first half of 2026, authorities received 856 complaints, but only 37 resulted in substantive action. Administrative guidance accounted for 80.5% of outcomes.
Flagged practices included false claims of specialist status, unsupported treatment effects and credentials, and promotional patient-review programs. Enforcement rates for online and banner advertising were lower than those for signage and naming violations, highlighting the difficulty of monitoring promotional material that spreads and disappears quickly.
Regional differences were also substantial. Sejong and Gangwon recorded no material penalties, while Jeju and North Gyeongsang showed relatively higher rates. Similar advertising can therefore produce different outcomes depending on the local authority, supporting calls for common standards and continuous monitoring.
Advertisers should manage creative based on legality and consumer harm, not the probability of a penalty. Snapchat Adds Disclaimer Links to Pharma Ads — Up to Four CTAs per Placement shows why regulated advertising requires both platform features and an internal approval process.
Treat specialist claims, treatment outcomes, before-and-after images and testimonials as separate risk categories, and retain evidence for every claim. Apply one conservative approval standard across regions instead of following the least restrictive interpretation. Keep screenshots and revision histories after launch for later review.
The reported figure was 4.3%, or 37 out of 856 complaints from 2021 through the first half of 2026.
Examples included false specialist status, unsupported treatment or credential claims, and promotional testimonial programs.
To apply what you just read to your own site, start with a free audit of where things are now.
A strategist replies within 24 hours on business days.
Korea's transport ministry reviewed online property ads for a year and flagged 10,412 suspected violations. False listing details made up 55.4% and missing mandatory information 40% — a breakdown with lessons for any regulated ad category.
Korea's KISA is treating KakaoTalk brand messages sent on SMS-only consent as illegal spam. Here's the per-channel marketing consent rule, the fine that follows, and what brands running CRM in Korea should audit now.
South Korea will ban AI fake-doctor endorsements in medical device advertising from December 10, with penalties of up to three years in prison.